ChatBot Beta

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:46:43 2025-02-11 am EST			5-day change	1st Jan Change
86.49 ^USD	+0.10%		-4.99%	-13.34%

09:29am	HSBC Adjusts Price Target on Merck to $115 From $130	MT
07:59am	Merck Says Health Canada Approves Keytruda for Non-Small Cell Lung Cancer	MT

Analyst Reco.

HSBC Adjusts Price Target on Merck to $115 From $130	09:29am	MT
Bernstein Adjusts Price Target on Merck & Co. to $95 From $110, Keeps Market Perform Rating	06:02am	MT
TD Cowen Downgrades Merck & Co. to Hold From Buy, Adjusts Price Target to $100 From $121	Feb. 10	MT
UBS Adjusts Price Target on Merck to $105 From $120, Maintains Buy Rating	Feb. 05	MT
Wells Fargo Adjusts Merck Price Target to $97 From $110	Feb. 05	MT
Citigroup Adjusts Merck Price Target to $115 From $125	Feb. 05	MT
Jefferies Adjusts Merck Price Target to $138 From $150	Feb. 05	MT
JPMorgan Adjusts Merck Price Target to $130 From $145	Feb. 05	MT
Daiwa Securities Adjusts Merck Price Target to $95 From $100	Feb. 05	MT
Goldman Sachs Adjusts Merck Price Target to $129 From $135	Feb. 05	MT
Leerink Partners Adjusts Merck Price Target to $113 From $118	Feb. 05	MT
Deutsche Bank Adjusts Merck Price Target to $128 From $132, Maintains Buy Rating	Feb. 05	MT
Morgan Stanley Trims Price Target on Merck to $106 From $113, Keeps Equalweight Rating	Feb. 05	MT
Deutsche Bank Adjusts Price Target on Merck to $132 From $140	Feb. 04	MT
Analysts recommendations: Accenture, Lockheed Martin, Hershey, Tapestry, Occidental Petroleum...	Jan. 31
Analysts recommendations: Wizz Air, Glencore, J Sainsbury, Merck, Occidental Petroleum…	Jan. 31
Citigroup Adjusts Price Target on Merck & Co. to $125 From $130, Keeps Buy Rating	Jan. 28	MT
TD Cowen Adjusts Price Target on Merck to $121 From $140	Jan. 27	MT
Leerink Partners Adjusts Merck Price Target to $118 From $119, Maintains Outperform Rating	Jan. 24	MT
Morgan Stanley Adjusts Merck Price Target to $113 From $123, Maintains Equal Weight Rating	Jan. 21	MT
Guggenheim Adjusts Price Target on Merck to $122 From $130, Maintains Buy Rating	Jan. 17	MT
Leerink Partners Adjusts Price Target on Merck $119 From $136, Keeps Outperform Rating	Jan. 13	MT
UBS Cuts Price Target on Merck to $120 From $125, Maintains Buy Rating	Jan. 08	MT
Analyst recommendations: Adobe, Merck, Take-Two, Palantir, Experian...	Jan. 08
Truist Securities Downgrades Merck to Hold From Buy, Adjusts Price Target to $110 From $130	Jan. 08	MT

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Analyst Reco.

Filters